These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 8207420

  • 1. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 2. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 3. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Sep; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 4. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 5. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW, Abercrombie ED.
    J Neurochem; 1999 Apr 28; 72(4):1516-22. PubMed ID: 10098856
    [Abstract] [Full Text] [Related]

  • 6. Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.
    Sader-Mazbar O, Loboda Y, Rabey MJ, Finberg JP.
    Br J Pharmacol; 2013 Nov 28; 170(5):999-1013. PubMed ID: 23992249
    [Abstract] [Full Text] [Related]

  • 7. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB, Angers M.
    Biochem Pharmacol; 1987 May 15; 36(10):1731-5. PubMed ID: 3109430
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 15; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 9. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 15; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul 15; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 12. Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo study.
    Brannan T, Prikhojan A, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1994 Jul 15; 8(1-2):99-105. PubMed ID: 7893380
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep 15; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 16. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED, Bonatz AE, Zigmond MJ.
    Brain Res; 1990 Aug 13; 525(1):36-44. PubMed ID: 2123121
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC, Delini-Stula A, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug 13; 292(1):9-14. PubMed ID: 934359
    [Abstract] [Full Text] [Related]

  • 19. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K, Dluzen DE.
    J Neural Transm (Vienna); 1996 Aug 13; 103(11):1295-305. PubMed ID: 9013416
    [Abstract] [Full Text] [Related]

  • 20. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M.
    J Neural Transm Park Dis Dement Sect; 1990 Aug 13; 2(1):15-22. PubMed ID: 2113388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.